NLRP3 and atherosclerosis: As interest in the application of NLRP3 inhibitors for CVD gains momentum, it becomes increasingly important to address the research gap concerning the activation of the NLRP3 inflammasome in other atherosclerosis-relevant cell types, including cell-specific blocking strategies.